nivolumab
bms
['nivolumab', 'nivo']
#asco22 important surgical point here. patients who received nivolumab with neoadjuvant chemotherapy were more likely to go to surgery. with nivolumab, 93% went to resection (7% cancelled) compared to control arm, where only 69% went to resection (31% cancelled). 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him